Step Therapy Policy - Commercial plans
Customize your policy alerts
Sign up for Baylor Scott & White Health Plan Policy 306 alerts
Get alerted when Policy 306 changes without checking for updates manually.
Monitor payer policy activity
This policy governs step therapy requirements for commercial-plan medical outpatient drugs and devices, requiring a trial of applicable preferred alternatives before coverage of non-preferred products. It applies to providers requesting coverage for members and must be used with the member’s benefit document and referenced Baylor Scott & White Health Plan policies.
Vykoura was added to the leucovorin class.
The policy history documents additions and updates to several drug classes, including infliximab agents and specialty oncology and ophthalmic products.
A reference to policy 239 was removed.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.